Biotech Archives - SylvaCap

Home Biotech

The End of Breast Cancer Could Be Through Prevention Rather Than...

Ross Silver - August 10, 2018

Epidiolex Set for FDA Approval, Cannabis M&A Heats Up

Ross Silver - May 18, 2018

Vital Therapies, Inc. (Nasdaq: VTL): The Biotech Name Smart Money Owns

Ross Silver - May 9, 2018

Two Small Caps Leading the CRISPR Biotech Revolution

Ross Silver - May 1, 2018

FDA Advisory Committee Unanimously Approves Cannabis Based Drug, Epidiolex: 4 Small...

Ross Silver - April 26, 2018

Why We Like Small Cap Biotech

Ross Silver - April 24, 2018

The Difference Between Anti-Aging and True Regenerative Medicine

Greg Harrison - April 16, 2018

Atossa – A Play on Immunotherapy Cancer Agent CAR T

Ross Silver - March 22, 2018

The Impact of Steel and Aluminum Tariffs: Part II

SylvaCap Media Staff - March 12, 2018

Catalyst Rich Biotech is Focused on Making 2018 a Pivotal Year

Ross Silver - February 15, 2018

Interview with Adi Mohanty, Co-Chief Executive Officer, BioTime, Inc. (BTX)

Ross Silver - January 31, 2018

Takeaways from JP Morgan Conference and CES

Ross Silver - January 16, 2018

12 3 Page 1 of 3